<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862696</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.469</article-id><article-id pub-id-type="other">EPP0287</article-id><article-id pub-id-type="pii">S0924933824004693</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Spano</surname><given-names>L.</given-names></name><xref rid="aff1007" ref-type="aff">
<sup>1</sup></xref><xref rid="cor0330" ref-type="corresp">
<sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marie-Claire</surname><given-names>C.</given-names></name><xref rid="aff1007" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Godin</surname><given-names>O.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1009" ref-type="aff">
<sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Leboyer</surname><given-names>M.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1009" ref-type="aff">
<sup>3</sup></xref><xref rid="aff1010" ref-type="aff">
<sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aouizerate</surname><given-names>B.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1011" ref-type="aff">
<sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lefrere</surname><given-names>A.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1012" ref-type="aff">
<sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Belzeaux</surname><given-names>R.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1013" ref-type="aff">
<sup>7</sup></xref><xref rid="aff1014" ref-type="aff">
<sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Courtet</surname><given-names>P.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1015" ref-type="aff">
<sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Olie</surname><given-names>E.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1016" ref-type="aff">
<sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dubertret</surname><given-names>C.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1017" ref-type="aff">
<sup>11</sup></xref><xref rid="aff1018" ref-type="aff">
<sup>12</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schwan</surname><given-names>R.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1019" ref-type="aff">
<sup>13</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aubin</surname><given-names>V.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1020" ref-type="aff">
<sup>14</sup></xref></contrib><contrib contrib-type="author"><name><surname>Roux</surname><given-names>P.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1021" ref-type="aff">
<sup>15</sup></xref><xref rid="aff1022" ref-type="aff">
<sup>16</sup></xref></contrib><contrib contrib-type="author"><name><surname>Polosan</surname><given-names>M.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1023" ref-type="aff">
<sup>17</sup></xref></contrib><contrib contrib-type="author"><name><surname>Samalin</surname><given-names>L.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1024" ref-type="aff">
<sup>18</sup></xref></contrib><contrib contrib-type="author"><name><surname>Haffen</surname><given-names>E.</given-names></name><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1025" ref-type="aff">
<sup>19</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bellivier</surname><given-names>F.</given-names></name><xref rid="aff1007" ref-type="aff">
<sup>1</sup></xref><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1026" ref-type="aff">
<sup>20</sup></xref></contrib><contrib contrib-type="author"><name><surname>Etain</surname><given-names>B.</given-names></name><xref rid="aff1007" ref-type="aff">
<sup>1</sup></xref><xref rid="aff1008" ref-type="aff">
<sup>2</sup></xref><xref rid="aff1026" ref-type="aff">
<sup>20</sup></xref></contrib></contrib-group><aff id="aff1007">
<sup>1</sup><institution>Universit&#x000e9; Paris Cit&#x000e9;</institution>, INSERM UMR-S 1144, Optimisation Th&#x000e9;rapeutique en Neuropsychopharmacologie OTeN, <city>Paris</city>
</aff><aff id="aff1008">
<sup>2</sup><institution>Fondation FondaMental</institution>
</aff><aff id="aff1009">
<sup>3</sup><institution>Universit&#x000e9; Paris Est Cr&#x000e9;teil</institution>, INSERM U955, IMRB, Translational NeuroPsychiatry Laboratory</aff><aff id="aff1010">
<sup>4</sup>AP-HP, H&#x000f4;pitaux Universitaires Henri Mondor, D&#x000e9;partement M&#x000e9;dico-Universitaire de Psychiatrie et d&#x02019;Addictologie (DMUIMPACT), <institution>F&#x000e9;d&#x000e9;ration Hospitalo-Universitaire de M&#x000e9;decine de Pr&#x000e9;cision en Psychiatrie (FHU ADAPT)</institution>, <city>Cr&#x000e9;teil</city>
</aff><aff id="aff1011">
<sup>5</sup>Centre Hospitalier Charles Perrens, Laboratoire NutriNeuro (UMR INRA 1286), <institution>Universit&#x000e9; de Bordeaux</institution>, <city>Bordeaux</city>
</aff><aff id="aff1012">
<sup>6</sup>P&#x000f4;le de Psychiatrie, <institution>Assistance Publique H&#x000f4;pitaux de Marseille</institution>
</aff><aff id="aff1013">
<sup>7</sup>INT-UMR7289, <institution>CNRS Aix-Marseille Universit&#x000e9;</institution>, <city>Marseille</city>
</aff><aff id="aff1014">
<sup>8</sup><institution>Universit&#x000e9; Montpellier</institution>, <city>Montpellier</city>
</aff><aff id="aff1015">
<sup>9</sup>Department of Emergency Psychiatry and Acute Care, <institution>CHU Montpellier, IGF, Univ. Montpellier, CNRS</institution>, <city>INSERM</city>, <country>Cr&#x000e9;teil</country>
</aff><aff id="aff1016">
<sup>10</sup>Department of Emergency Psychiatry and Acute Care, <institution>CHU Montpellier, IGF, Univ. Montpellier, CNRS</institution>, <city>INSERM</city>, <country>Montpellier</country>
</aff><aff id="aff1017">
<sup>11</sup><institution>AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, Service de Psychiatrie et Addictologie, H&#x000f4;pital Louis Mourier</institution>, <city>Colombes</city>
</aff><aff id="aff1018">
<sup>12</sup><institution>Universit&#x000e9; de Paris</institution>, Inserm UMR1266, Sorbonne Paris Cit&#x000e9;, Facult&#x000e9; de M&#x000e9;decine, <city>Paris</city>
</aff><aff id="aff1019">
<sup>13</sup><institution>Universit&#x000e9; de Lorraine</institution>, Centre Psychoth&#x000e9;rapique de Nancy, Inserm U1254, <city>Nancy</city>
</aff><aff id="aff1020">
<sup>14</sup><institution>P&#x000f4;le de Psychiatrie, Centre Hospitalier Princesse Grace</institution>, <city>Monaco</city>
</aff><aff id="aff1021">
<sup>15</sup><institution>Centre Hospitalier de Versailles, Service Universitaire de Psychiatrie d&#x02019;Adulte et d&#x02019;Addictologie</institution>, <city>Le Chesnay</city>
</aff><aff id="aff1022">
<sup>16</sup>Equipe DisAP-PsyDev, CESP, <institution>Universit&#x000e9; Versailles Saint- Quentin-en-Yvelines &#x02013; Paris-Saclay
</institution>, <city>Inserm</city>, <country>Villejuif</country>
</aff><aff id="aff1023">
<sup>17</sup><institution>Universit&#x000e9; Grenoble Alpes</institution>, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, <city>Grenoble</city>
</aff><aff id="aff1024">
<sup>18</sup><institution>Centre Hospitalier et Universitaire</institution>, D&#x000e9;partement de Psychiatrie, Universit&#x000e9; Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal (UMR 6602), <city>Clermont-Ferrand
</city>
</aff><aff id="aff1025">
<sup>19</sup><institution>Service de Psychiatrie de l&#x02019;Adultre</institution>, CIC-1431 INSERM, CHU de Besan&#x000e7;on, Laboratoire de Neurosciences, UFC, <city>UBFC</city>, <country>Besan&#x000e7;on</country>
</aff><aff id="aff1026">
<sup>20</sup><institution>AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord</institution>, DMU Neurosciences, H&#x000f4;pital Fernand Widal, D&#x000e9;partement de Psychiatrie et de M&#x000e9;decine Addictologique, <city>Paris</city>, <country>France</country>
</aff><author-notes><corresp id="cor0330">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="444">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S219</fpage><lpage>S219</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824004693a.pdf"/><abstract><sec id="sec1981"><title>Introduction</title><p>A 10-15 years decrease in life expectancy has been observed in individuals with bipolar disorder (BD) and has been associated with premature cellular aging, but mechanisms involved remain unclear. Our team recently identified a subgroup of young individuals with prematurely shortened telomere length (TL).</p></sec><sec id="sec1982"><title>Objectives</title><p>The aims of the present study were to replicate this observation in a larger sample and to analyze the expression levels of genes associated with age or TL in a subsample of these individuals.</p></sec><sec id="sec1983"><title>Methods</title><p>
TL was measured by qPCR using peripheral blood DNA from 542 individuals with BD. Clustering analyzes were performed with age and TL as classification variables to identify similar groups.</p><p>Gene expression of 29 genes, including 20 associated with age and 9 with TL, was analyzed by RT-qPCR using peripheral blood RNA in a subgroup of 129 individuals. Gene expressions were compared between groups obtained from the previous clustering analyzes by Kruskal-Wallis and Mann-Whitney tests.</p></sec><sec id="sec1984"><title>Results</title><p>Clustering analyzes identified 3 subgroups and replicated the clustering previously described: a subgroup of aged individuals with a low TL (mean age : 51.73 years ; mean TL : 2), a subgroup of young individuals with a high TL (mean age : 29.02 years ; mean TL : 4.36) and a subgroup of young individuals but with a low TL (mean age : 29.64 years ; mean TL : 1.96).&#x000a0;None of the tested clinical variables were significantly associated with this subgroup.</p><p>Furthermore, gene expression level analyzes showed that only <italic toggle="yes">POT1</italic> expression was different between the two subgroups of young individuals, with a downregulation of <italic toggle="yes">POT1</italic> expression in the subgroup with a lower TL level. POT1 is a protein involved in the maintenance of TL. POT1 binds to another protein TPP1 allowing the recruitment of telomerase, the enzyme which extends TL. Our hypothesis is that in the subgroup presenting a lower <italic toggle="yes">POT1</italic> expression, the POT1-TPP1 complex cannot form and thus prevents telomerase recruitment and TL elongation.</p></sec><sec id="sec1985"><title>Conclusions</title><p>This study confirms, on a larger sample, the existence of a subgroup of young individuals with BD presenting accelerated cellular aging. The observed decrease of <italic toggle="yes">POT1</italic> expression level suggests a newly described cellular mechanism in individuals with BD, that may contribute to telomere shortening.</p></sec><sec id="sec1986"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>